News and Events
closerlook appoints Monika Klimek as vice president to oversee its expanded data science division
Chicago, Ill., August 5, 2020 — Digital-native agency closerlook, inc. has expanded its data science division and hired Monika Klimek to manage the unit as vice president of data science. Klimek will lead her team to engineer transformative experiences and deliver brand growth.
“As our clients shift to digital-first strategies, more of them are placing a significant focus on using data and analyses to create personalized, cross-channel experiences that are relevant and engaging,” said Steve Tulk, chief technology officer. “Monika’s expertise in transforming data from campaigns and third-party sources into valuable insights will be critical as our clients seek to maximize impact and accelerate growth. Several of our client brands are already benefiting from her knowledge.”
The newly expanded data science division applies the latest technologies, such as smart tagging, data enrichment and predictive algorithms, to build brand-supported tactics that can be utilized across all channels and maximize return on investment. All members of the data science team are trained on General Data Protection Regulation (GDPR) compliance and Health Insurance Portability and Accountability Act (HIPAA) regulations.
“My goal is to amplify innovation at every level of the brand experience at closerlook,” Klimek said. “Our team is tasked with creating unique data solutions and software products driven by advanced methodologies such as machine learning and AI. These tools and capabilities enable us to build comprehensive data strategies that are tailored for each brand’s specific needs.”
Klimek joins the agency with more than 20 years of experience in the data science field. Approximately 10 of those years have been in the agency space. She worked for agencies such as Sapient Razorfish, The Marketing Store and Crispin Porter. She graduated from the University of Colorado Boulder and has two master’s degrees.
How to use data to capture value in pharma
Value capture encompasses the strategies for bringing a new therapy to the market as effectively and efficiently as possible. If the value creation process was well-informed by the patient journey, the needs of providers and the realities of payer economics, then there is likely a differentiated product that is ready for market.Read more
Value extraction – mining for gold in late-stage products
During the last few years in the run-up to LOE, there is often enormous pricing pressure from competitive products and aggressive health plans.Read more